Genes are associated with individual variations in drug response. Many genes have been intensely studied in a range of populations and characterized for various drug groups. It has been found that 90% of top-selling medications only treat 30–50% of patients and this is causing a burden on the healthcare system. Pharmacogenomics (PGx) plays an important role in identifying responders and non-responders to medications to help develop a personalised treatment plan and reduce this burden.
Utilisation of Pharmacogenomic Testing in Clinical Research webinar is hosted by Thermo Fisher Scientific and brings together a panel of experts who will be discussing the potential impact of PGx research and the real-world impact of pharmacogenomics on personalised medicine.
Key Learning Objectives:
info@wilam.comAn initiative ofBioMelbourne NetworkLevel 4, ANZAC House4 Collins StreetMelbourne Vic 3000
Wilam means home in the Woi-wurrung language of the Wurundjeri People of the Kulin Nation, the Traditional Owners of the lands on which we are based.We respectfully acknowledge the Traditional Custodians of the unceded lands and waters of Victoria, the Bunurong, Eastern Maar, Gunaikurnai, Wadawurrung and Wurundjeri Woi-wurrung peoples, on which we live and work. We pay respect to their Elders past and present. We acknowledge the significant contribution that they and other Aboriginal and Torres Strait Islander people have made and continue to make to the research and knowledge systems that inform our community and our sector. We acknowledge that Aboriginal and Torres Strait Islander people continue to live in a spiritual and sacred relationship with this country and recognise our responsibility to continue to work towards reconciliation.